Stada Arzneimittel AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Stada Arzneimittel AG with three other
pharmaceutical manufacturers in Europe:
H. Lundbeck A/S
sales of 14.59 billion Danish Kroner [US$2.15 billion]
of which 22%
was Other Pharmaceuticals),
(19.65 billion Swedish Kronor [US$2.23 billion]
of which 62%
was RX), and
based in France
(1.52 billion Euro [US$1.67 billion]
of which 73%
was Specialty Care).
Stada Arzneimittel AG reported sales of 2.12 billion Euro (US$2.32 billion)
December of 2015.
increase of 2.6%
versus 2014, when the company's sales were 2.06 billion Euro.
Sales at Stada Arzneimittel AG have increased during each of the previous five years
(and since 2010, sales have increased a total of 30%).
Sales of Branded Products saw an increase
that was more than double the company's growth rate: sales were up
6.6% in 2015, from
800.56 million Euro to 853.60 million Euro.
Not all segments of Stada Arzneimittel AG experienced an increase in sales in 2015:
sales of Commercial Business fell 0.1% to 43.91 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).
Stada Arzneimittel AG also experienced decreases in sales in
Generics (down 0.0% to 1.22 billion Euro)